StoneBridge Ventures Inc. Total Liabilities

Latest as of September 2025: ₩7.20 Billion KRW ≈ $4.88 Million USD

StoneBridge Ventures Inc. total liabilities. Based on the latest financial reports, StoneBridge Ventures Inc. (330730) has total liabilities worth ₩7.20 Billion KRW (≈ $4.88 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 330730 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of StoneBridge Ventures Inc. (2019–2024)

Total liabilities of StoneBridge Ventures Inc. from 2019 to 2024. This chart illustrates how StoneBridge Ventures Inc.'s total liabilities have evolved over time, based on quarterly financial data.

StoneBridge Ventures Inc. Competitors by Total Liabilities

The table below lists competitors of StoneBridge Ventures Inc. ranked by their total liabilities.

Company Country Total Liabilities
ROK Resources Inc
V:ROK
Canada CA$35.39 Million
Diatreme Resources Ltd
AU:DRX
Australia AU$2.23 Million
180 Degree Capital Corp
NASDAQ:TURN
USA $2.85 Million
GAMEVIL Inc
KQ:063080
Korea ₩266.43 Billion
EyeGene Inc
KQ:185490
Korea ₩13.78 Billion
Lowell Resources Fund
AU:LRT
Australia AU$2.41 Million
PA Nova S.A.
WAR:NVA
Poland zł481.44 Million
Lida Holdings Ltd
TW:4552
Taiwan NT$1.64 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down StoneBridge Ventures Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see StoneBridge Ventures Inc. total assets.

Liquidity & Leverage Metrics

StoneBridge Ventures Inc. Total Liabilities Ratios Explained

StoneBridge Ventures Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.86 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.08 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how StoneBridge Ventures Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for StoneBridge Ventures Inc. (2019–2024)

The table below shows the annual total liabilities of StoneBridge Ventures Inc. from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 ₩7.15 Billion
≈ $4.85 Million
-24.87%
2023-12-31 ₩9.52 Billion
≈ $6.45 Million
-22.12%
2022-12-31 ₩12.23 Billion
≈ $8.28 Million
-27.99%
2021-12-31 ₩16.98 Billion
≈ $11.50 Million
+98.42%
2020-12-31 ₩8.56 Billion
≈ $5.80 Million
-22.73%
2019-12-31 ₩11.07 Billion
≈ $7.50 Million
--

About StoneBridge Ventures Inc.

KQ:330730 Korea Asset Management
Market Cap
$49.57 Million
₩73.14 Billion KRW
Market Cap Rank
#21747 Global
#1312 in Korea
Share Price
₩4195.00
Change (1 day)
-0.71%
52-Week Range
₩4165.00 - ₩7070.00
All Time High
₩7517.89
About

Stonebridge Ventures Inc. is a venture capital firm. The firm operates as a subsidiary of Stonebridge Capital Inc. It considers growth capital, secondary investments and invests across all stages: seeding, early to mid-stage and late stage. The firm considers investments in manufacturing including smart farm, smart city, smart factory; artificial intelligence; research and development; biotechnol… Read more